Adis International is a one-stop solution for all of your drug information and strategic planning needs. From product conception to product launch, Adis has the tools and resources you need to Create the Clinical Connection. Adis International publishes a range of medical information journals and newsletters; provides competitive drug information database solutions, and creates customized communications for healthcare professionals worldwide. Through the recent acquisition of the Genesis Group Adis’ also provides modeling and forecasting of the pharmaceutical, diagnostic and healthcare industries. All Adis’ products and services are created to support global drug development, marketing and planning.

Adis International was established in Australia during the 1960s to provide pharmaceutical drug information to Australian and New Zealand doctors. The company launched its first international review journal and flagship product, Drugs, in 1971. Since then Adis has grown to become a worldwide drug solutions provider with a reputation for scientific integrity and editorial excellence with offices on four continents.

Adis’ network of offices in the USA, Europe (UK, France, Italy, and Spain), Japan, New Zealand, Australia and Hong Kong, is part of the Wolters Kluwer International Health Science Group (WKIHS), which provides Adis with a true global perspective and depth of resources critical for the healthcare communication industry. Adis is a member of the WKIHS Group. Other members of WKIHS Group include Lippincott Williams & Wilkins, Facts & Comparisons, Kluwer Academic Publishers and Ovid Technologies.